Methods and systems for controlled deployment of needles in tissue
View Patent ↗Needles are deployed in tissue under direct ultrasonic or other imaging. To aid in deploying the needle, a visual needle guide is projected on to the image prior to needle deployment. Once the needle guide is properly aligned, the needle can be deployed. After needle deployment, a safety boundary and treatment region are projected on to the screen. After confirming that the safety boundary and treatment regions are sufficient, the patient can be treated using the needle.
1. A method for deploying at least one needle in tissue, said method comprising:
positioning a probe having a deployable needle proximate a surface of the tissue;
providing a real time image of the tissue including both an anatomical feature to be treated and sensitive anatomic structures;
overlaying the image with a projected treatment region and a projected safety boundary based on the position of the probe;
repositioning the probe to align the projected treatment region and safety boundary on the real time image so that the treatment region includes at least a portion of the anatomical feature to be treated and the sensitive anatomic structure remain outside of the safety boundary; and
deploying the needle from the probe after the probe has been repositioned; wherein the anatomical feature to be treated includes a fibroid.
2. A method as in claim 1 , further comprising:
updating the image of the treatment region and the projected safety boundary on the image of tissue based on the actual position of the needle after the needle has been deployed; and
visually confirming that the anatomical feature to be treated is within the treatment region and that the sensitive anatomic structures are outside of the safety boundary.
3. A method as in claim 2 , wherein visually confirming comprises confirming that the needle is no closer than 0.5 cm to the sensitive anatomic structures features.
4. A method as in claim 2 , further comprising enabling a treatment device if the sensitive anatomic structures are outside of the safety boundary.
5. A method as in claim 4 , wherein enabling comprises responding to a prompt from the treatment device asking if the sensitive anatomic structures are outside of the safety boundary.
6. A method as in claim 1 , wherein the probe is positioned in a uterus.
7. A method as in claim 1 , wherein the sensitive anatomic structure to be maintained outside of the safety boundary includes a serosa.
8. A method as in claim 1 , wherein the image is provided by a transducer on the probe.
9. A method as in claim 1 , further comprising:
marking a location of the needle after the needle has been deployed; and
updating the projected treatment region and the projected safety boundary based on the marked location on the needle.